Press release
Tuberculosis Testing Marketis Expanding at a 3.9% CAGR between 2017 and 2025
Leading players within the market are: Hain Lifescience GmbH, Danaher Corporation, Thermo Fisher Scientific Inc., Epistem plc, Oxford Immunotec Ltd, Hologic Inc., Becton, F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN, Akonni Biosystems Inc., Creative Diagnostics, Alere Inc., Cepheid, bioMérieux SA, and LIONEX Diagnostics & Therapeutics GmbH.
Obtain Report Details @ https://www.transparencymarketresearch.com/tuberculosis-testing-market.html
Asia Pacific Emerging as Leading Market for Tuberculosis Testing
As per a report by Transparency Market Research, the global tuberculosis testing market is anticipated to be worth US$3.18 bn by 2025, expanding at a mere 3.9% CAGR between 2017 and 2025. By geography, the market is led by Asia Pacific, which is estimated to expand at a 4.9% CAGR from 2017 to 2025. On the basis of type, the market is led by the culture based tests is leading and is likely to continue to do so throughout the forecast period on account of the ability to accurately diagnose and confirm active tuberculosis.
Hospital Laboratories and Physician's Office Laboratories Generating High Demands for Tuberculosis Testing
On the basis of end users, the market generates maximum revenues from the hospital laboratories market. The cost effective tests offered by hospital laboratories is the reason behind the leading status of this segment. The physician's office laboratories segment is also a key end user segment.
Request For Sample of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267
Efforts by Government and Non-Governmental Organizations to Spread Awareness Regarding Tuberculosis Meets Success
As per the WHO, 10.4 mn new cases of tuberculosis had been registered in 2015. 56% of these cases comprised of men. The growing incidences of this disease is boding well for the growth of the global tuberculosis testing market. The market also benefits from the increasing awareness among the masses spread through constant efforts by governments and non-governmental organizations. Governments are also offering fee waivers and tax credits.
Request For Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2267
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tuberculosis Testing Marketis Expanding at a 3.9% CAGR between 2017 and 2025 here
News-ID: 1197032 • Views: …
More Releases from Transparency Market Research
Gas Compressor Market Outlook 2036: Global Industry Expected to Reach US$ 41.0 B …
The global gas compressor market was valued at US$ 23.2 Bn in 2025 and is projected to reach US$ 41.0 Bn by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. This steady growth trajectory reflects the structural importance of gas compression systems across upstream, midstream, and downstream gas value chains. Rising natural gas consumption, expansion of pipeline and LNG infrastructure, and national energy…
Anesthesia Drugs Market to be Worth USD 12.6 Bn by 2036 - By Drug / By Applicati …
The global anesthesia drugs market was valued at US$ 7.6 billion in 2025 and is projected to reach US$ 12.6 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2036. This steady growth trajectory reflects the essential and non-substitutable role of anesthesia drugs in modern healthcare systems. As surgical interventions continue to rise globally-across both elective and emergency procedures-the demand for safe, effective,…
Single-Atom Catalysts Market Size is Expected to Expand from US$ 177.8 Million t …
The global single-atom catalysts (SACs) market is poised for remarkable growth as industries seek highly efficient, cost-effective, and sustainable catalytic solutions. Valued at US$ 177.8 million in 2025, the market is projected to reach US$ 1,000.2 million by 2036, expanding at a robust compound annual growth rate (CAGR) of 17.0% from 2026 to 2036. This rapid expansion reflects the growing importance of advanced catalysis in energy, chemicals, environmental protection, and…
Non-specific Endonuclease Market to Reach USD 726.6 Million by 2036, Supported b …
The non-specific endonuclease market is witnessing steady growth, driven by the expanding use of molecular biology tools across biotechnology, pharmaceuticals, diagnostics, and academic research. Non-specific endonucleases are enzymes that cleave nucleic acids without requiring a specific recognition sequence, making them highly valuable for applications such as DNA/RNA degradation, sample preparation, viscosity reduction, and contamination control. Their broad activity profile differentiates them from restriction enzymes and enables versatile usage across multiple…
More Releases for Tuberculosis
Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the…
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research…
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of…
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032.
Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over…
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does.
March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per…
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
Ocular tuberculosis is a type…
